Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  580 results for ""Mesothelioma""

Your Filters

Publication : lancet
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pembrolizumab plus chemotherapy for pleural mesothelioma.

Subjects: MESOTHELIOMA; PEMBROLIZUMAB; CANCER chemotherapy

  • Source: Lancet. Dec2023, Vol. 402 Issue 10419, p2266-2267. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.

Subjects: MESOTHELIOMA; CLINICAL trials; PEMBROLIZUMABITALY; FRANCE; CANADA

  • Source: Lancet. Dec2023, Vol. 402 Issue 10419, p2295-2306. 12p.

Record details

Read More Add to Saved list
×
Academic Journal

Mesothelin-family proteins and diagnosis of mesothelioma.

Subjects: MESOTHELIOMA; TUMOR markers; ASBESTOS

  • Source: Lancet. 11/15/2003, Vol. 362 Issue 9396, p1612-1616. 5p. 1 Chart, 3 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Malignant mesothelioma.

Subjects: MESOTHELIOMA; TUMOR treatment; CANCER risk factors

  • Source: Lancet. 7/30/2005, Vol. 366 Issue 9483, p397-408. 12p. 3 Color Photographs, 1 Black and White Photograph, 1 Diagram, 1 Graph.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Continuing increase in mesothelioma mortality in Britain.

Subjects: MESOTHELIOMA; MORTALITYUNITED Kingdom

  • Source: Lancet. 3/4/1995, Vol. 345 Issue 8949, p535. 5p. 3 Charts, 2 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Heterogeneity of treatment effects in malignant pleural mesothelioma.

Subjects: TREATMENT effectiveness; MESOTHELIOMA; TREATMENT effect heterogeneity

  • Source: Lancet. Jul2021, Vol. 398 Issue 10297, p301-302. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Pleural mesothelioma: little evidence, still time to do trials.

Subjects: CANCER treatment; MESOTHELIOMA; TUMOR treatment

  • Source: Lancet. 9/25/2004, Vol. 364 Issue 9440, p1183-1185. 3p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey.

Subjects: *MESOTHELIOMA; *GENETICS of disease susceptibility; *ETIOLOGY of diseases

  • Source: Lancet. 2/10/2001, Vol. 357 Issue 9254, p444. 2p. 1 Diagram.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A new standard for malignant pleural mesothelioma.

Subjects: MESOTHELIOMA; CISPLATIN; BEVACIZUMAB

  • Source: Lancet. 4/2/2016, Vol. 387 Issue 10026, p1352-1354. 3p.

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.

Subjects: PLEURAL effusions; MESOTHELIOMA; THORACOSCOPY

  • Source: Lancet. 9/20/2014, Vol. 384 Issue 9948, p1118-1127. 10p. 1 Diagram, 3 Charts, 2 Graphs.

Record details

Read More Add to Saved list
×
  • 1-10 of  580 results for ""Mesothelioma""